AMBS up Wed 22% Thrus 160% Friday 32% Today 95%! News is out.
The company has recently had lab conformation back regarding it's main drug to help treat Parkinson's Disease the report showed the drug was a success in clinical trial with animals. Since this report the stock has been on fire! But it is still trading for pennies on the dollar near the 52 week low! Check them out.
Also the co founder for Amgen announced plans to purchase 1 million shares of AMBS in the next 10 days! Michale J Fox Foundation also awarded AMBS a research grant. Low float makes this stock rocket on news and the volume the past two days has been over 45 million shares traded!